alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
First Amend. to Jacuzzi 2004 Stock Incentive Plan



 





Exhibit 10.2




FIRST AMENDMENT

TO

JACUZZI BRANDS, INC.

2004 STOCK INCENTIVE PLAN




     WHEREAS, Jacuzzi Brands, Inc. (the “Company”) previously adopted the
Jacuzzi Brands, Inc. 2004 Stock Incentive Plan (the “Plan”);



     WHEREAS, Section 16(i) of the Plan permits the Company to amend the Plan
at any time;



     WHEREAS, the Company wishes to amend the Plan to clarify the date of the
annual awards; and



     WHEREAS, under such circumstances, the Company is permitted to amend the
Plan without the approval of the shareholders of the Company.



     NOW, THEREFORE, effective October 1, 2004, the Plan is hereby amended as
follows:




     1. Section 11(a)(ii) is amended by deleting the word “calendar” in the
first sentence therein, and replacing it with the word “fiscal”.




     2. Appendix I is amended by deleting the definition of “Annual Grant Date”
therein, and replacing it with the following text:




     “
“Annual Grant Date” means the first business day of each fiscal year.”



     IN WITNESS WHEREOF, the Company has caused this amendment to the Plan to
be duly executed as of the 1st day of October 2004.


	 	 	 	 	 
	 	JACUZZI BRANDS, INC.

 	 
	 	By:  	/s/  STEVEN C. BARRE
 	 
	 	 	Name:  	Steven C.  Barre 	 
	 	 	Title:  	Senior Vice President and
General Counsel
II 

111TH CONGRESS 

1ST SESSION S. 2850 

To permit the use of Federal funds from the Community Development Block 

Grant Program to be used to remediate damage from the installation 

of tainted drywall, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 8, 2009 

Mr. VITTER introduced the following bill; which was read twice and referred 

to the Committee on Banking, Housing, and Urban Affairs 

A BILL 

To permit the use of Federal funds from the Community 

Development Block Grant Program to be used to remediate damage from the installation of tainted drywall, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Chinese Drywall 

5 Homeowners Assistance Act’’. 

WReier-Aviles on DSKGBLS3C1PROD with BILLS

2 

•S 2850 IS

1 SEC. 2. USE OF FEDERAL FUNDS TO REMEDIATE DAMAGE 

2 DONE BY TAINTED DRYWALL. 

3 (a) ROAD HOME PROGRAM.—Notwithstanding any 

4 other provision of law, any Federal funds provided to the 

5 Road Home Program created by the Louisiana Recovery 

6 Authority and funded by amounts made available to the 

7 State of Louisiana from the community development block 

8 grant program under title I of the Housing and Commu9 nity Development Act of 1974 (42 U.S.C. 5301 et seq.) 

10 may be used to provide any resident of the State of Lou11 isiana, whether a participant or nonparticipant in the 

12 Road Home Program, with such monetary assistance as 

13 may be necessary to repair or replace tainted drywall. 

14 (b) CDBG AMOUNTS.—Notwithstanding any other 

15 provision of law, including any provision under title I of 

16 the Housing and Community Development Act of 1974 

17 (42 U.S.C. 5301 et seq.), the Secretary of Housing and 

18 Urban Development may permit any State or unit of gen19 eral local government receiving assistance pursuant to sec20 tion 106 of such Act to use such assistance to provide 

21 homeowners residing in such State or unit of general local 

22 government with such monetary assistance as may be nec23 essary to repair or replace tainted drywall. 

24 (c) DEFINITION.—As used in this section, the term 

25 ‘‘tainted drywall’’ means drywall that— 

WReier-Aviles on DSKGBLS3C1PROD with BILLS

3 

•S 2850 IS

1 (1) was manufactured in the People’s Republic 

2 of China; 

3 (2) was imported into the United States during 

4 the period beginning on January 1, 2004, and end5 ing on December 31, 2008; and 

6 (3) contains elevated levels of sulphur or stron7 tium. 

Æ 

WReier-Aviles on DSKGBLS3C1PROD with BILLS
Exhibit 13.1

Section 906 Certification

The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31,
2015 (the Report) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the Exchange Act) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

José Antonio Álvarez, the Chief Executive Officer, José G. Cantera, the Chief Financial Officer and José Doncel,
the Chief Accounting Officer of Banco Santander, S.A., each certifies that, to the best of his knowledge:



| | 1. | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
| | -- | --------------------------------------------------------------------------------------------------



| | 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Banco Santander, S.A.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: April 20, 2016



/s/ José Antonio ÁlvarezName:

José Antonio ÁlvarezTitle:

Chief Executive Officer/s/ José G. CanteraName:

José G. CanteraTitle:

Chief Financial Officer/s/ José DoncelName:

José DoncelTitle:

Chief Accounting Officer
#### In the Matter of Anonymous, an Applicant for Admission to the Bar of the State of New York, Appellant.

Decided October 19, 2010

Appeal dismissed, without costs, by the Court of Appeals, sua sponte, upon the ground that no substantial constitutional question is directly involved.
**EXHIBIT 31.2**

 

**CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

 

I, David L. Weinberg, Chief Financial Officer of the Company, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Columbia Laboratories, Inc.; 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; 

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-14 and 15d-14) for the registrant and we have: 

 

a) designed suchdisclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterlyreport is being prepared; 

 

b) evaluated the effectiveness of theregistrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and 

 

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on ourevaluation as of the Evaluation Date; 

 

5. The registrant’s othercertifying officer and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors: 

 

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s abilityto record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and 

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

6. The registrant’s other certifying officer and I have indicated in thisquarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions withregard to significant deficiencies and material weaknesses. 

 

Date: May 10, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### International Trade Administration

This is a decision consolidated pursuant to Section 6(c) of the Educational, Scientific, and Cultural Materials Importation Act of 1966 (Pub. L. 89-651, as amended by Pub. L. 106-36; 80 Stat. 897; 15 CFR part 301). Related records can be viewed between 8:30 A.M. and 5:00 P.M. in Room 3705, U.S. Department of Commerce, 14th and Constitution Avenue., NW, Washington, D.C.

*Docket Number: 09-048.*                     Applicant: North Dakota State University, Fargo, ND 58102. Instrument: Electron Microscope. Manufacturer: JEOL, Japan. Intended Use: See notice at 74 FR 46973, September 14, 2009.                 

*Docket Number: 09-049.*                     Applicant: Washington State University, Pullman, WA 99164. Instrument: Electron Microscope. Manufacturer: FEI Company, Czech Republic. Intended Use: See notice at 74 FR 46973, September 14, 2009.                 

*Docket Number: 09-050.*                     Applicant: Stanford University, Stanford, CA 94305. Instrument: Electron Microscope. Manufacturer: FEI Company, the Netherlands. Intended Use: See notice at 74 FR 46973, September 14, 2009.                 

*Comments:*                     None received. Decision: Approved. No instrument of equivalent scientific value to the foreign instrument, for such purposes as these instruments are intended to be used, was being manufactured in the United States at the time the instruments were ordered. Reasons: Each foreign instrument is an electron microscope and is intended for research or scientific educational uses requiring an electron microscope. We know of no electron microscope, or any other instrument suited to these purposes, which was being manufactured in the United States at the time of order of each instrument.                

Dated: October 15, 2009.

Christopher Cassel,

Director, Subsidies Enforcement Office, Import Administration.

[FR Doc. E9-25337 Filed 10-20-09; 8:45 am]

BILLING CODE 3510-DS-S
Exhibit 10.42

SENIOR VICE PRESIDENT OF OPERATIONS 2001 INCENTIVE PLAN

PURPOSE:To reward the Senior Vice President of Operations for achievement of planned sales and planned controllable
operating profit, less regional and operations department overhead costs.

PLAN YEAR:The plan begins January 1, 2001 and ends on December 30, 2001.

INCENTIVE PAY:The incentive pay pool is equal to a percentage of the Regional Managers' incentive payout, a percent of
salary for achievement of minimum sales objectives, and a percent of salary for achievement of minimum controllable operating profit less regional and operations department overhead costs. See
attached schedule.

ELIGIBILITY:Employed by Fresh Choice on the date incentive checks are calculated.

BUDGET CHANGES DURING THE YEAR:In the following situations, budgets may be revised to reflect the increased sales
potential/change from which incentive pay is calculated: 1) the timing of remodels versus budget (completion dates a well as which stores are actually remodeled); and 2) adding new
stores or closing existing stores.

Plan Intent:The Company retains the discretion to revise or cancel the program at any time with or without notice.

---

QuickLinks
# Summary

&"Times New Roman,Bold"Drills/Skills Summary		

&P	

&P	

# Code Page

# image1.png
[Federal Register Volume 74, Number 205 (Monday, October 26, 2009)]
[Notices]
[Page 55054]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-25507]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism; Special Emphasis Panel AA-3 Study Section Members 
Conflict.
    Date: November 19, 2009.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5635 Fishers Lane, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Lorraine Gunzerath, PhD, MBA, Scientific Review 
Officer, National Institute on Alcohol Abuse and Alcoholism Office 
of Extramural Activities, Extramural Project Review Branch, 5635 
Fishers Lane, Room 2121, Bethesda, MD 20892-9304, 301-443-2369, 
<a href="/cdn-cgi/l/email-protection#fe92998b90849b8c9fbe939f9792d0909796d0999188"><span class="__cf_email__" data-cfemail="d9b5beacb7a3bcabb899b4b8b0b5f7b7b0b1f7beb6af">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Career Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical 
Research and Research Support Awards, National Institutes of Health, 
HHS)

    Dated: October 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-25507 Filed 10-23-09; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Form of Series D 7% Convertible Preferred Stock Certificate



 Exhibit 4.1 
  

					
	Number PD             	  	CELL THERAPEUTICS, INC.	  	*            * Shares
		  	A Washington Corporation	  	Series D Preferred Stock

 THIS CERTIFIES THAT
*            * is the record holder of *            
(            )* shares of Series D Preferred Stock of Cell Therapeutics, Inc. (the “Corporation”) transferable only on the share register of the
Corporation by the holder, in person or by such holder’s duly authorized attorney, upon surrender of this certificate properly endorsed or assigned. 
 This certificate and the shares represented hereby shall be held subject to all of the provisions of the Articles of Incorporation and the Bylaws of the Corporation and any amendments thereto, a copy of each of which
is on file at the office of the Corporation and made a part hereof as fully as though the provisions of said Articles of Incorporation and Bylaws were imprinted in full on this Certificate, to all of which the holder of this Certificate, by
acceptance hereof, assents and agrees to be bound. 
 The shares represented by this Certificate are convertible into shares of Common Stock
as set forth in the Articles of Incorporation of the Corporation and shall be so converted upon the occurrence of certain events as set forth in said Articles of Incorporation. 
 The Corporation will furnish without charge to each shareholder who so requests, the powers, designations, preferences and relative, participating,
optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences or rights. 
 IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed by its duly authorized officers this «Date». 
  

					
	  	 		 	  
	Donald W. Wyatt, Secretary	 		 	Louis A. Bianco, Executive Vice President, Finance and Administration








 FOR VALUE RECEIVED, THE UNDERSIGNED HEREBY SELLS, ASSIGNS AND TRANSFERS UNTO
                                        
            
                                        
                     SHARES REPRESENTED BY THE WITHIN CERTIFICATE AND DOES HEREBY IRREVOCABLY CONSTITUTE AND APPOINT
                                        
     ATTORNEY TO TRANSFER THE SAID SHARES ON THE SHARE REGISTER OF THE WITHIN NAMED CORPORATION WITH FULL POWER OF SUBSTITUTION IN THE PREMISES. 
  


			
	DATED 	 	 


	
	
	  
	(Signature)


 NOTICE: THE SIGNATURE ON THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THIS
CERTIFICATE, IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATEVER.
CERTIFICATION
PURSUANT TO
 18 U.S.C.
SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002
 
 I,
Daniel S. Tamkin, Chief Executive Officer of Synergx Systems certify
that:
 
 1.  I
have reviewed this quarterly report on Form 10-QSB of Synergx Systems
Inc.;
 
 2.  Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;
 
 3.
Based on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of registrant as of,
and for, the periods presented in this quarterly report;
 
 4.  The
registrant’s other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and have:
 
 a)  Designed
such disclosure controls and procedures, or caused such  disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;
  b)  Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and    presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period cover by this report based on such evaluation; and
 
 c)  Disclosed
in this quarterly report any change in the registrant’s internal control over
financial reporting that occurred during registrant’s most recent fiscal quarter
that has materially affected, or reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
 
 5.  The
registrant’s other certifying officers and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of registrant’s board of directors
(or persons performing the equivalent functions);
 
 a)
All significant deficiencies in material weakness the design or operation of
internal controls over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
  b)  Any fraud, whether or not material, that involves management or
other employees who have a  significant role in the registrant’s
internal control over financial reporting.
 
 Date:      
February   13, 2008
  /s/DANIELS S. TAMKIN
 Daniel S. Tamkin
 Chief Executive
Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE DECEMBER
31, 1997 AUDITED FINANCIAL STATEMENTS OF SUNPORT MEDICAL CORPORATION AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS IN FORM
10-KSB FOR THE YEAR ENDED DECEMBER 31, 1997.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                       1,373,000
<SECURITIES>                                         0
<RECEIVABLES>                                  309,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,681,000
<PP&E>                                          45,000
<DEPRECIATION>                                  35,000
<TOTAL-ASSETS>                               1,746,000
<CURRENT-LIABILITIES>                          599,750
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,408,000
<OTHER-SE>                                 (5,263,000)
<TOTAL-LIABILITY-AND-EQUITY>                 1,746,000
<SALES>                                         30,000
<TOTAL-REVENUES>                                30,000
<CGS>                                          234,000
<TOTAL-COSTS>                                  334,000
<OTHER-EXPENSES>                             (101,847)
<LOSS-PROVISION>                               100,000
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (407,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (305,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (406,643)
<EPS-PRIMARY>                                    (.02)
<EPS-DILUTED>                                    (.02)


</TABLE>